Clearbridge Investments, LLC Eli Lilly & CO Transaction History

Clearbridge Investments, LLC

$119 Billion
Q2 2024

A detailed history of Clearbridge Investments, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clearbridge Investments, LLC holds 1,131,967 shares of LLY stock, worth $1.03 Billion. This represents 0.86% of its overall portfolio holdings.

Number of Shares

1,131,967

Previous 1,131,967 -0.0%

Holding current value

$1.03 Billion

Previous $1.02 Billion -0.0%

% of portfolio

0.86%

Previous 0.86%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $662,531 - $830,862	-914 Reduced 0.08%	1,131,967 $1.02 Billion
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $95.9 Million - $128 Million	161,918 Added 16.68%	1,132,881 $881 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $10.5 Million - $12.4 Million	19,976 Added 2.1%	970,963 $566 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $5.33 Million - $7.35 Million	-12,260 Reduced 1.27%	950,987 $511 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $3.61 Million - $4.83 Million	-10,303 Reduced 1.06%	963,247 $452 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $207 Million - $243 Million	667,410 Added 218.01%	973,550 $334 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $326,373 - $380,290	-1,015 Reduced 0.33%	306,140 $112 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $793,973 - $904,815	-2,678 Reduced 0.86%	307,155 $99.3 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $147,726 - $173,453	530 Added 0.17%	309,833 $100 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $14.4 Million - $17.8 Million	-61,169 Reduced 16.51%	309,303 $88.6 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $30.2 Million - $37.4 Million	-134,159 Reduced 26.59%	370,472 $102 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $4.7 Million - $5.78 Million	-21,197 Reduced 4.03%	504,631 $117 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $7.11 Million - $9.19 Million	-39,365 Reduced 6.96%	525,828 $121 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $7.07 Million - $9.15 Million	43,014 Added 8.24%	565,193 $106 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $63.2 Million - $83.6 Million	484,411 Added 1282.6%	522,179 $88.2 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $878,928 - $1.02 Million	6,011 Added 18.93%	37,768 $5.59 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $3.26 Million - $3.93 Million	23,909 Added 304.65%	31,757 $5.21 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $66,699 - $71,542	-814 Reduced 9.4%	7,848 $663,000
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $382,190 - $424,192	-4,959 Reduced 36.41%	8,662 $741,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,621	13,621 $1.12 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Eli Lilly & CO Transaction History